USP1 and neoplasm: A recent study found that the USP1 inhibitor pimozide inhibited the deubiquitination of MAX/MYC proteins by USP1, induced apoptosis, autophagy, and cell cycle arrest in tumor cells, and improved rituximab treatment of diffuse large B-cell lymphoma resistance.179